JS
Joel Saban
President

Joel Saban insider trades: Diplomat Pharmacy (DPLO) stock buys and sales

President, Diplomat Pharmacy Last trade Nov 20, 2017 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2011
3
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Joel reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 20, 2017DPLO↑ Buy$152K
Mar 11, 2015SXCI↓ Sell$45K
Mar 10, 2015SXCI↓ Sell$368K
Mar 6, 2015SXCI↓ Sell$118K
Sep 8, 2014SXCI↓ Sell$83K
Mar 24, 2014SXCI↓ Sell$682K
Mar 10, 2014SXCI↓ Sell$215K
Mar 7, 2014SXCI↓ Sell$61K
Sep 9, 2013SXCI↓ Sell$91K
Mar 12, 2013SXCI↓ Sell$54K
Mar 8, 2013SXCI↓ Sell$977K
Sep 10, 2012SXCI↓ Sell$73K
Mar 12, 2012SXCI↓ Sell$26K
Sep 13, 2011SXCI↓ Sell$42K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Joel Saban's insider trades

Joel Saban is President at Diplomat Pharmacy (DPLO). Since Sep 13, 2011, Joel has reported 1 open-market purchase worth $152K and 13 sales worth $2.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (12 filings), grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DPLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.